VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Documentation the subject not effectively treated  │ Documentation the subject not effectively treated  │     100 │
│ with CPAP therapy. (Examples include non-          │ with CPAP therapy. (Examples include non-          │         │
│ compliance, discomfort, undesirable side effects,  │ compliance, discomfort, undesirable side effects,  │         │
│ symptoms persist despite use). Subjects who have   │ symptoms persist despite use). Subjects who have   │         │
│ been prescribed, but refuse to try CPAP would be   │ been prescribed, but refuse to try CPAP would be   │         │
│ considered intolerant                              │ considered intolerant                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Age 22 or above                                    │ Age 22 or above                                    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Willing and capable to have stimulation hardware   │ Willing and capable to have stimulation hardware   │     100 │
│ permanently implanted, and to use the patient      │ permanently implanted, and to use the patient      │         │
│ remote to activate the stimulation                 │ remote to activate the stimulation                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Willing and capable to return for all follow-up    │ Willing and capable to return for all follow-up    │     100 │
│ visits and conduct sleep studies at home,          │ visits and conduct sleep studies at home,          │         │
│ including the evaluation procedures and filling    │ including the evaluation procedures and filling    │         │
│ out questionnaires                                 │ out questionnaires                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Willing and capable of providing informed consent  │ Willing and capable of providing informed consent  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any anatomical finding that would compromise the   │ Any anatomical finding that would compromise the   │     100 │
│ performance of upper airway stimulation, such as   │ performance of upper airway stimulation, such as   │         │
│ the presence of complete concentric collapse of    │ the presence of complete concentric collapse of    │         │
│ the soft palate                                    │ the soft palate                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any condition or procedure that has compromised    │ Any condition or procedure that has compromised    │     100 │
│ neurological control of the upper airway           │ neurological control of the upper airway           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients who are unable or do not have the         │ Patients who are unable or do not have the         │     100 │
│ necessary assistance to operate the patient remote │ necessary assistance to operate the patient remote │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients who are pregnant or plan to become        │ Patients who are pregnant or plan to become        │     100 │
│ pregnant                                           │ pregnant                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients who will require magnetic resonance       │ Patients who will require magnetic resonance       │     100 │
│ imaging (MRI)                                      │ imaging (MRI)                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with an implantable device that may be    │ Patients with an implantable device that may be    │     100 │
│ susceptible to unintended interaction with the     │ susceptible to unintended interaction with the     │         │
│ Inspire system                                     │ Inspire system                                     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any chronic medical illness or condition that      │ Any chronic medical illness or condition that      │     100 │
│ contraindicates a surgical procedure under general │ contraindicates a surgical procedure under general │         │
│ anesthesia, as judged by the clinical study        │ anesthesia, as judged by the clinical study        │         │
│ Investigator                                       │ Investigator                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Active psychiatric disease (psychotic illness,     │ Active psychiatric disease (psychotic illness,     │     100 │
│ major depression, or acute anxiety attacks) which  │ major depression, or acute anxiety attacks) which  │         │
│ prevents subject compliance with the requirements  │ prevents subject compliance with the requirements  │         │
│ of the investigational study testing               │ of the investigational study testing               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any other reason the investigator deems subject is │ Any other reason the investigator deems subject is │     100 │
│ unfit for participation in the study               │ unfit for participation in the study               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Likely suffer moderate-to-severe OSA based on      │ Likely suffer moderate-to-severe OSA based on      │      89 │
│ history and physical or have an established        │ history and physical or have an established        │         │
│ diagnosis of OSA (AHI \>= 15) based on a prior     │ diagnosis of OSA (20=AHI=65) based on a prior in-  │         │
│ sleep study                                        │ lab Polysomnography                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Central + mixed apneas \> 25% of the total apnea-  │ Central + mixed apneas > 25% of the total apnea-   │      99 │
│ hypopnea index (AHI)                               │ hypopnea index (AHI)                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has a terminal illness with life expectancy \< 12  │ Has a terminal illness with life expectancy < 12   │      99 │
│ months                                             │ months                                             │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                             │ CHIA Criteria                                     │   Score │
╞═══════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Contraindications                             │ Has a terminal illness with life expectancy < 12  │      31 │
│                                               │ months                                            │         │
├───────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 22 Years             │ Patients who are pregnant or plan to become       │      35 │
│                                               │ pregnant                                          │         │
├───────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Additional exclusions for study purposes only │ Willing and capable of providing informed consent │      40 │
╘═══════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒═══════════════════════════════════╤═══════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                 │   Score │
╞═══════════════════════════════════╪═══════════════════════════════╪═════════╡
│ Must have minimum age of 22 Years │ Body Mass Index (BMI) of > 32 │      32 │
╘═══════════════════════════════════╧═══════════════════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 96
Average Levenshtein Ratio of individual lines: 86.9047619047619
OverAll Ratio: 91.45238095238095
